March: Congratulations to former lab member Kimberly Maxfield, Ph.D., on her recent publication in JAMA Online First, Precision Dosing A Clinical and Public Health Imperative and her Podcast Interview on Conversations with Dr Bauchner, JAMA Network.
March 2021: Welcome new lab member Harshel Patel.
Feb 2021: Congratulations to Chun-Chun Cheng on her new position as Instructor in the Department of Experimental Radiation Oncology at MD Anderson Cancer Center.
January 2021: Congratulations to Luis Reza for being selected to receive the Gilman Special Opportunities Award.
December 2020: Congratulations to Zane Gibbs for receiving the 2020 Alfred and Mabel Gilman Memorial Awards for Excellence in Research for Student of the Year! Zane discovered the mechanism by which the testis factor ZNF165, which gets re-activated in triple negative breast cancer cells, regulates an oncogenic SMAD3 TGFbeta signaling network. In addition to a cash prize, his name will be engraved on the Alfred and Mabel Gilman Memorial Awards plaque located at the Pharmacology office.
October 2020: Congratulations to Chun-Chun on the publication of her paper. Sperm-specific COX6B2 enhances oxidative phosphorylation, proliferation, and survival in human lung adenocarcinoma
June 2020: Congratulations to Luis Reza for passing his Qualifying Exam with flying colors!
June 2020: Congratulation to Zane on the publication of his paper. The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer
August 2019: Welcome new Post Doc Magda Delgado, who will be starting in September.
August 2019: Good Luck to Lily Cormier and to Emily Greaves as they leave to continue their undergraduate education.
August 2019: Congratulations to Zack on starting his position of Clinical Research Associate at Medpace in Irving, TX
July 2019: Congratulations to Luis on being selected for the NIH Pharmacological Studies Training Grant.
June 2019: Congratulations to Zack on the publication of his paper. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
June 2019: Welcome new lab member Luis C. Reza.
November 2018: Congratulations to Brandt on the publication of his paper. HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress
September 2018: Congratulations to Brandt on starting his position of Life Sciences Consultant at Putnam Associates in Boston, MA
July 2017: Lab receives grant from St Baldrick’s Foundation for Targeting Fragility in the TNFa Signaling Pathway in Ewing Sarcoma.
June 2017: Welcome new Post Doc Chun-Chun Cheng.
May 2017: Congratulations to Zack and Zane for passing their Qualifying Exams.
March 2017: Welcome new Lab Manager Kathleen McGlynn Tucker.
June 2016: Congratulations to Zane on being awarded the Pharmacological Sciences training grant.
March 2016: Congratulations to Zack on being awarded a grant from the NSF Graduate Research Fellowship Program as well as the Dean's Discretionary Award.
March 2016: Congratulations to Zack on previously being awarded the MoDTS training grant.
March 2016: Welcome new lab members Zane Gibbs and Zachary Gallegos.
March 2016: Congratulations to Brandt on being awarded the CMB training grant.
February 2016: Congratulations to Patrick on successfully defending his thesis: FATE1: Contributor to Tumor Cell Fitness and Example of an Oncogene-Activated Cancer Testis Antigen.
January 2016: Lab receives award from 1 Million 4 Anna Foundation to study CT-antigens in Ewing Sarcoma, a collaborative effort with the Amatruda, Deberardinis, McFadden and Kittler Laboratories. https://www.1million4anna.org/
December 2015: Congratulations to Kim on attaining her position at the AAAS.
November 2015: Congratulations to Kim and Patrick on the publication of their paper. Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer
June 2015: Congratulations to Patrick on being awarded his F30 entitled: Contribution of Fetal and Adult Testis Expressed to Tumor Cell Survival.
April 2015: Angelique chairs a Methods Workshop at AACR entitled: Methods for Pharmacogenomics Discovery and Interpretation.
August 2011: News Feature A ballsy search for cancer targets
May 2009: Angelique Whitehurst Joined the Faculty at UNC Chapel Hill